Individualized Treatment for TMJ Dysfunction
(TMD3c Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to find the best way to ease jaw pain from temporomandibular disorders (TMD) using personalized treatment plans. Researchers compare two approaches: a new, highly tailored coping skills training called the Individualized Assessment and Treatment Program (IATP) and a more traditional cognitive-behavioral therapy, both alongside standard dental care. People experiencing jaw pain for more than three months and with a confirmed TMD diagnosis may be a good fit. The goal is to determine if the personalized approach can more effectively reduce pain, depression, and daily life disruptions.
As an unphased trial, this study offers participants the chance to contribute to innovative research that could lead to more effective treatments for TMD.
Will I have to stop taking my current medications?
The trial requires that you do not take narcotic pain medication. If you are currently taking narcotics for pain, you would need to stop before participating.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
In a previous study, patients who received cognitive-behavioral treatment (CBT) for temporomandibular disorder (TMD) experienced less pain and felt better overall. No major safety issues were reported, indicating that CBT is generally safe for this condition.
Specific safety data for the Individualized Assessment and Treatment Program (IATP) for TMD is not yet available. However, as this study is in its early stages and focuses on tailoring treatment to each patient's needs, it suggests a careful approach. This likely involves closely monitoring patient reactions to the treatment.
Overall, both treatment options in this study seem to prioritize patient safety, with no reports of serious side effects. For any concerns, discussing them with the researchers or a healthcare provider before joining the trial is advisable.12345Why are researchers excited about this trial?
Researchers are excited about the Individualized Assessment and Treatment Program (IATP) for TMJ dysfunction because it offers a highly personalized approach to managing pain. Unlike standard treatments that typically focus on general conservative dental care, this program integrates individualized coping skills training tailored to each patient's specific needs. This personalized strategy aims to enhance the effectiveness of pain management by addressing the unique psychological and behavioral factors contributing to each patient's condition. By combining standard care with this customized approach, there is potential for improved outcomes and a better quality of life for those suffering from TMJ dysfunction.
What evidence suggests that this trial's treatments could be effective for TMD?
Research has shown that cognitive-behavioral therapy (CBT), one of the treatments in this trial, can reduce pain and emotional issues in people with temporomandibular disorders (TMD). Studies have found that CBT not only eases pain but also lessens the impact of TMD on daily life and reduces symptoms of depression. Meanwhile, the Individualized Assessment and Treatment Program (IATP), another treatment option in this trial, aims to be even more effective by customizing treatment for each person. Early results suggest that IATP might lower pain, depression, and daily life disruption more than standard treatments. This approach focuses on improving coping skills, which could be important for managing long-term pain.16789
Who Is on the Research Team?
Mark D Litt, Ph.D.
Principal Investigator
UConn Health
Are You a Good Fit for This Trial?
This trial is for adults over 18 living in the Greater Hartford, CT area with facial pain or TMJ disorders. Participants must have a confirmed diagnosis of TMD and experience jaw pain for more than three months. It's not open to those on narcotic pain meds, with previous TMD surgery, severe TM joint damage, non-English speakers, neuropathic/odontogenic pain origins, certain comorbid conditions or current depression treatment.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-treatment Monitoring
Experience Sampling (ES) procedure conducted via smartphone app to gather information on patients' pain, momentary cognitions, affects, and coping behaviors
Treatment
Participants receive either STD+IATP or STD+CBT treatment, including 6 sessions of cognitive-behavioral coping skills training
Follow-up
Participants are monitored for changes in depressive symptoms, pain, interference, and coping ability at multiple follow-up points
What Are the Treatments Tested in This Trial?
Interventions
- Cognitive-Behavioral Treatment
- Individualized Assessment and Treatment Program
- Standard Conservative Care
Find a Clinic Near You
Who Is Running the Clinical Trial?
UConn Health
Lead Sponsor
National Institute of Dental and Craniofacial Research (NIDCR)
Collaborator